Sun Ophthalmics prepares to enter US ophthalmic market in 2016

A group within a large multinational drug maker is poised to enter the U.S. ophthalmic market and take a professional-centered approach in 2016.The new entity, Sun Ophthalmics, an arm of Sun Pharma, features a team of experienced ophthalmic executives who are preparing to introduce new products and build on existing product lines through partnerships and acquisitions.